Canada markets open in 6 hours 35 minutes

Voyageur Pharmaceuticals Ltd. (VM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0550+0.0050 (+10.00%)
At close: 12:44PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 7.63M
Enterprise Value 7.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.32
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.51

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 3-31.25%
S&P500 52-Week Change 321.33%
52 Week High 30.0900
52 Week Low 30.0350
50-Day Moving Average 30.0654
200-Day Moving Average 30.0593

Share Statistics

Avg Vol (3 month) 337.98k
Avg Vol (10 day) 325.38k
Shares Outstanding 5138.81M
Implied Shares Outstanding 6138.81M
Float 8124.63M
% Held by Insiders 110.21%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 49.54k
Short Ratio (Apr 15, 2024) 41.26
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.02%
Shares Short (prior month Mar 15, 2024) 42k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 07, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Mar 07, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 30, 2023
Most Recent Quarter (mrq)Feb 29, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.95%
Return on Equity (ttm)-71.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.19M
Net Income Avi to Common (ttm)-1.35M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)253.25k
Total Cash Per Share (mrq)0
Total Debt (mrq)40k
Total Debt/Equity (mrq)2.54%
Current Ratio (mrq)0.48
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-700.12k
Levered Free Cash Flow (ttm)-204.67k